Abstract
The first attempt to apply electrochemotherapy (ECT) to the brain was reported in 1993 by Salford et al. 1993 (1). They managed to significantly prolong the survival of RG2 glioma bearing Fischer-344 rats by 200% by iv administration of bleomycin followed by intracranial electrochemotherapy with exponential decaying pulses. In collaboration with the department of tumor immunology, Lund University, an ethyl-nitroso-urea induced rat glioma cell line (N32) is developed that produces glioma of malignant astrocytoma type with only half the growth rate of the RG2 cells (2). The N32 tumor implanted in rats was treated with intracranial electrochemotherapy and enhanced uptake of [111In]bleomycin from intracranial ECT was also demonstrated with a scintillation camera (3). 111In-labeled bleomycin has been used to investigate the uptake and retention after ECT treatment of subcutaneous N32 tumors (4).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Salford, L. G., Persson, R. B. R., Brun, A., Ceberg, C. P., Kongstad, P. C., and Mir, L. M. (1993) A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem. Biophys. Res. Commun. 194, 938–943.
Siesjö, P., Visse, P., Lindvall, M., Salford, L. G., and Sjögren, H.-O. (1993) Immunization with mutagen-treated (tum-) cells causes rejection of nonimmunogenic rat glioma isografts. Cancer Immunol. Immunother. 37, 67–74.
Engström, P. E., Persson, R. B. R., and Salford, L. G. (1997) Dynamic gamma camera studies of 111In-bleomycin complex in normal and glioma (N32, RG2) bearing rats after in vivo electropermeabilization using exponential high-voltage pulses. Proceedings of the Second World Congress on Biological Effects of Electrical and Magnetic fields, Bologna, Italy, 1997.
Engström, P., Salford, L. G., and Persson, B. R. R. (1998) Dynamic gamma camera studies of 111In-bleomycin complex in normal and glioma bearing rats after in vivo electropermeabilization using exponential high-voltage pulses. Bioelectrochem. Bioenerg. 46, 241–248.
Mir, L. M., Glass, L. F., Serša, G., Teissié, J., Domenge, C., Miklavčič, D., Jaroszeski, M. J., Orlowski, S., Reintgen, D. S., Rudolf, Z., Belehradek, M., Gilbert, R., Rols, M. P., Belehradek, J., Bachaud, J. M., DeConti, R., Štabuc, B., Čemažar, M., Coninx, P., and Heller, R. (1998) Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br. J. Cancer 77, 2236–2342.
Mir, L. M., Roth, C., Orlowski, S., Quintin-Colonna, F., Fradelizi, D., Belehradek, J., and Kourilsky, P. (1995) Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J. Immunother. 17, 30–38.
Aas, A. T., Brun, A., Blennow, C., Stromblad, S., and Salford, L. G. (1995) The RG2 rat glioma model. J. Neurooncol. 23, 175–183.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Salford, L.G., Engström, P., Persson, B.R.R. (2000). Treatment of Rat Glioma With Electrochemotherapy. In: Jaroszeski, M.J., Heller, R., Gilbert, R. (eds) Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery. Methods in Molecular Medicine, vol 37. Humana Press. https://doi.org/10.1385/1-59259-080-2:313
Download citation
DOI: https://doi.org/10.1385/1-59259-080-2:313
Publisher Name: Humana Press
Print ISBN: 978-0-89603-606-2
Online ISBN: 978-1-59259-080-3
eBook Packages: Springer Protocols